-
公开(公告)号:NO972559L
公开(公告)日:1997-08-05
申请号:NO972559
申请日:1997-06-05
Applicant: BASF AG
Inventor: BOEHM HANS-JOACHIM , KOSER STEFAN , MACK HELMUT , PFEIFFER THOMAS , SEITZ WERNER , HOEFFKEN HANS WOLFGANG , HORNBERGER WILFRIED , ZIERKE THOMAS
-
42.
公开(公告)号:ZA9510295B
公开(公告)日:1997-06-05
申请号:ZA9510295
申请日:1995-12-05
Applicant: BASF AG
Inventor: BOEHM HANS-JOACHIM , KOSER STEFAN , MACK HELMUT , PFEIFFER THOMAS , SEITZ WERNER , HOEFFKEN HANS WOLFGANG , HORNBERGER WILFRIED , ZIERKE THOMAS
-
公开(公告)号:NO972559D0
公开(公告)日:1997-06-05
申请号:NO972559
申请日:1997-06-05
Applicant: BASF AG
Inventor: BOEHM HANS-JOACHIM , KOSER STEFAN , MACK HELMUT , PFEIFFER THOMAS , SEITZ WERNER , HOEFFKEN HANS WOLFGANG , HORNBERGER WILFRIED , ZIERKE THOMAS
-
公开(公告)号:FI965039A
公开(公告)日:1997-02-14
申请号:FI965039
申请日:1996-12-16
Applicant: BASF AG
Inventor: BUEHM HANS-JOACHIM , KOSER STEFAN , MACK HELMUT , PFEIFFER THOMAS , SEITZ WERNER , HOEFFKEN HANS WOLFGANG , HORNBERGER WILFRIED
IPC: A61K31/40 , A61K38/00 , A61K38/05 , A61K38/55 , A61K47/48 , A61P7/02 , C07C279/00 , C07D205/04 , C07D207/06 , C07D207/16 , C07D207/48 , C07D211/60 , C07K5/06 , C07K5/065 , C07K5/072 , C07K5/078 , C07K
Abstract: Compounds of the formula and the salts thereof with physiologically tolerated acids and the stereoisomers thereof, in which the substituents have the meanings stated in the description, are described. Also disclosed are intermediates for their preparation. The compounds are suitable for controlling diseases.
-
公开(公告)号:DK0570375T3
公开(公告)日:1995-07-03
申请号:DK91920137
申请日:1991-11-21
Applicant: BASF AG
Inventor: SCHMIED BERNHARD , HOEFFKEN HANS WOLFGANG , HORNBERGER WILFRIED , BERNARD HARALD
IPC: A61K38/55 , A61K38/00 , A61P7/02 , C07K7/06 , C07K14/815
Abstract: PCT No. PCT/EP91/02191 Sec. 371 Date Jul. 29, 1993 Sec. 102(e) Date Jul. 29, 1993 PCT Filed Nov. 21, 1991 PCT Pub. No. WO92/13879 PCT Pub. Date Aug. 20, 1992.Peptides of the formula where X, A1-A7 Y and W have the meanings stated in the description, and the preparation thereof are described. The peptides are suitable for controlling diseases.
-
公开(公告)号:CA2419078A1
公开(公告)日:2003-02-10
申请号:CA2419078
申请日:2001-08-09
Applicant: BASF AG
Inventor: GENESTE HERVE , GRAEF CLAUDIA ISABELLA , KLING ANDREAS , LAUTERBACH ARNULF , HORNBERGER WILFRIED , SUBKOWSKI THOMAS
IPC: C07D401/12 , A61K31/55 , A61K45/00 , A61K45/06 , A61P3/10 , A61P3/14 , A61P5/18 , A61P7/02 , A61P7/10 , A61P9/00 , A61P9/10 , A61P9/12 , A61P9/14 , A61P13/12 , A61P17/02 , A61P17/06 , A61P19/00 , A61P19/02 , A61P19/10 , A61P29/00 , A61P31/04 , A61P31/10 , A61P31/12 , A61P33/00 , A61P35/00 , A61P35/04 , A61P41/00 , A61P43/00 , C07D277/28 , C07D403/12 , C07D471/04
Abstract: The invention relates to novel compounds which bind to integrin receptors, i n particular as ligands for the .alpha.V.beta.3 integrin receptor, the use thereof and pharmaceutical preparations containing said compounds.
-
公开(公告)号:CA2411549A1
公开(公告)日:2002-12-05
申请号:CA2411549
申请日:2001-06-06
Applicant: BASF AG
Inventor: SUBKOWSKI THOMAS , HORNBERGER WILFRIED , GRAEF CLAUDIA ISABELLA , SEITZ WERNER , LAUTERBACH ARNULF , LANGE UDO , KLING ANDREAS , GENESTE HERVE
IPC: C07D223/10 , A61K31/55 , A61K31/5513 , A61K45/00 , A61K45/06 , A61P3/10 , A61P5/18 , A61P7/00 , A61P7/02 , A61P9/00 , A61P9/10 , A61P9/12 , A61P13/12 , A61P17/00 , A61P17/02 , A61P17/06 , A61P19/00 , A61P19/02 , A61P29/00 , A61P31/00 , A61P31/12 , A61P33/00 , A61P35/00 , A61P43/00 , C07D263/48 , C07D277/08 , C07D307/68 , C07D333/38 , C07D401/12 , C07D401/14 , C07D403/12 , C07D409/12 , C07D409/14 , C07D413/12 , C07D417/12 , C07D417/14 , C07D471/04 , C07D495/04 , C07K5/023
Abstract: The invention relates to the use of cyclic compounds as ligands of integrin receptors, in particular as ligands of the .alpha.v.szlig.3 integrin recepto r. The invention also relates to the novel compounds, to the use thereof and to pharmaceutical preparations which contain said compounds. Examples of said compounds include benzazepines, benzodiazepines and thieno[3,2-b]azepines, used for treating arteriosclerosis, rheumatoid arthritis, restenosis after vessel damage or stent implantation, angioplasty, acute kidney failure, microangiopathy associated with angiogenesis, diabetic angiopathy, thrombocy te- mediated vascular occlusion, arterial thrombosis, congestive heart-failure, myocardial infarct, apoplexy, cancer, osteoporosis, hypertension, psoriasis or viral, parasitic or bacterial diseases, inflammation, wound healing, hyperparathyroidism, Paget's bone disease, malignant hypercalcemia, or metastatic osteolytic lesions.
-
公开(公告)号:CZ2002439A3
公开(公告)日:2002-11-13
申请号:CZ2002439
申请日:2000-08-01
Applicant: BASF AG
Inventor: KLING ANDREAS , GENESTE HERVE , LANGE UDO , LAUTERBACH AMULF , GRAEF CLAUDIA ISABELLA , SUBKOWSKI THOMAS , HOLZENKAMP UTA , MACK HELMUT , SADOWSKI JENS , HORNBERGER WILFRIED , LAUX VOLKER
IPC: A61K31/4402 , A61K31/55 , A61K31/5513 , A61P3/14 , A61P5/18 , A61P7/02 , A61P9/00 , A61P9/08 , A61P9/10 , A61P9/12 , A61P9/14 , A61P13/12 , A61P17/02 , A61P17/06 , A61P19/00 , A61P19/08 , A61P19/10 , A61P29/00 , A61P31/04 , A61P31/12 , A61P33/00 , A61P35/00 , A61P35/04 , A61P43/00 , C07D213/74 , C07D223/20 , C07D243/38 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D409/12 , C07D409/14 , C07D417/06 , C07D417/12 , C07D417/14 , C07D471/04 , C07D495/04 , C07D495/14 , C07D243/10 , C07D487/04
Abstract: The invention relates to novel compounds which bind to integrin receptors, and to the preparation thereof and the use thereof as drugs.
-
公开(公告)号:CZ20020439A3
公开(公告)日:2002-11-13
申请号:CZ20020439
申请日:2000-08-01
Applicant: BASF AG
Inventor: KLING ANDREAS , GENESTE HERVE , LANGE UDO , LAUTERBACH AMULF , GRAEF CLAUDIA ISABELLA , SUBKOWSKI THOMAS , HOLZENKAMP UTA , MACK HELMUT , SADOWSKI JENS , HORNBERGER WILFRIED , LAUX VOLKER
IPC: A61K31/4402 , A61K31/55 , A61K31/5513 , A61P3/14 , A61P5/18 , A61P7/02 , A61P9/00 , A61P9/08 , A61P9/10 , A61P9/12 , A61P9/14 , A61P13/12 , A61P17/02 , A61P17/06 , A61P19/00 , A61P19/08 , A61P19/10 , A61P29/00 , A61P31/04 , A61P31/12 , A61P33/00 , A61P35/00 , A61P35/04 , A61P43/00 , C07D213/74 , C07D223/20 , C07D243/38 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D409/12 , C07D409/14 , C07D417/06 , C07D417/12 , C07D417/14 , C07D471/04 , C07D495/04 , C07D495/14 , C07D243/10 , C07D487/04
CPC classification number: C07D401/06 , C07D223/20 , C07D243/38 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D409/12 , C07D409/14 , C07D417/06 , C07D417/12 , C07D417/14 , C07D471/04 , C07D495/04 , C07D495/14
-
公开(公告)号:BG63697B1
公开(公告)日:2002-09-30
申请号:BG10183597
申请日:1997-08-15
Applicant: BASF AG
Inventor: BOEHM HANS-JOACHIM , HOEFFKEN HANS W , HORNBERGER WILFRIED , KOSER STEFAN , MACK HELMUT , PFEIFFER THOMAS , SEITZ WERNER , ZIERKE THOMAS
IPC: A61K31/00 , A61K38/55 , A61P7/02 , C07D205/04 , C07D207/16 , C07D213/53 , C07D213/63 , C07D213/72 , C07D213/78 , C07D213/79 , C07D239/28 , C07D241/14 , C07D241/24 , C07D401/12 , C07K5/06 , C07K5/062 , C07K5/078 , A61K31/40 , A61K31/445 , A61K31/495
Abstract: The description relates to compounds of formula in which A, B, D, R' and R have the meanings given in the specification. the compounds am suitable for the treatment of diseases The novel compounds are produced via compounds of the formula H2N-CH2.G-M in which G and M have the meanings given in the specification. 3 claims
-
-
-
-
-
-
-
-
-